Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
138.79%
↑ 358% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
30.29%
Historical baseline
PeriodValue
2025138.79%
2024-200.77%
2023-13.05%
2022-179.46%
2021278.82%
2020-155.37%
2019466.42%
2018-97.27%
201762.84%
20161.95%